Schlumberger Receives UK Approval for ChampionX Merger, Plans Closing Wednesday Schlumberger secures UK regulatory approval for ChampionX merger, targeting closing Wednesday to enhance oilfield services portfolio. #Schlumberger #ChampionXMerger
Coca-Cola Europacific Partners Continues Share Buyback with Latest Purchases Coca-Cola Europacific Partners advances share buyback program, signaling confidence in growth and capital return strategy. #CocaColaEP #ShareBuyback
American Express Reports June Card Loan Delinquency and Write-Off Rates American Express reports June card loan delinquency and write-off rates, reflecting credit quality trends amid economic shifts. #AmericanExpress #CreditRisk
BioXcel Therapeutics Receives USPTO Allowance for New Igalmi Dosing Patent BioXcel Therapeutics secures USPTO allowance for new Igalmi dosing patent, strengthening IP portfolio and market exclusivity. #BioXcelTherapeutics #IgalmiPatent
Simulations Plus Appoints Rose, Snyder & Jacobs as New Auditor Following Dismissal Simulations Plus appoints Rose, Snyder & Jacobs as new independent auditor after previous auditor dismissal, enhancing financial oversight. #SimulationsPlus #AuditChange
Aspac II Acquisition Corp. Issues $152,000 Promissory Note to Sponsor Aspac II Acquisition Corp. issues $152K promissory note to sponsor, supporting operational funding and transaction readiness. #AspacII #SPACFinance
MiNK Therapeutics Enters $50 Million At-The-Market Sales Agreement with B. Riley Securities MiNK Therapeutics secures $50M at-the-market sales agreement with B. Riley Securities to support clinical development and operational growth. #MiNKTherapeutics #CapitalRaise
Cayson Acquisition Corp Announces Resignation of Board Member Raymond Xia Cayson Acquisition Corp reports resignation of board member Raymond Xia, signaling potential shifts in governance. #CaysonAcquisition #BoardResignation
JPMorgan Chase Reports Second Quarter Net Income of $15 Billion JPMorgan Chase posts $15B net income in Q2, driven by strong trading and investment banking performance. #JPMorganChase #Q2Earnings
Verve Therapeutics Grants Retention Bonuses to CFO and COO Amid Pending Acquisition Verve Therapeutics awards retention bonuses to CFO and COO to ensure leadership stability during pending acquisition. #VerveTherapeutics #RetentionBonuses